Removal of focal segmental glomerulosclerosis (FSGS) factor suPAR using CytoSorb-Reference-Cited by-同舟云学术

Removal of focal segmental glomerulosclerosis (FSGS) factor suPAR using CytoSorb

Published:2017-03-29 Issue:6 Volume:32 Page:444-452
ISSN:0733-2459
Container-title:Journal of Clinical Apheresis
language:en
Short-container-title:J Clin Apher

Author:

Schenk Heiko¹^ORCID,Müller-Deile Janina¹^ORCID,Schmitt Roland¹,Bräsen Jan Hinrich²^ORCID,Haller Hermann¹,Schiffer Mario¹^ORCID

Affiliation:

1. Department of Nephrology and Hypertension; Hannover Medical School; Hannover Germany

2. Institute for Pathology; Hannover Medical School; Hannover Germany

Funder

Department of Nephrology and Hypertension of Hannover Medical School

Publisher

Wiley

Subject

Hematology,General Medicine

Reference39 articles.

1. New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis;Vincenti;Am J Transplant.,2005

2. FSGS recurrence in adults after renal transplantation;Rudnicki;Biomed Res Int.,2016

3. Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation;Zimmerman;Clin Nephrol.,1984

4. Proteinuria in rats induced by serum from patients with collapsing glomerulopathy;Avila-Casado Mdel;Kidney Int.,2004

5. Proteinuria after injection of human focal segmental glomerulosclerosis factor;Sharma;Transplantation.,2002

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemoadsorption in Organ Preservation and Transplantation: A Narrative Review;Life;2023-12-29

2. Efficacy of extracorporeal plasma therapy for adult native kidney patients with Primary FSGS: a Systematic review;Renal Failure;2023-02-10

3. Kinetics of SuPAR hemoadsorption in critical COVID-19 patients on renal replacement therapy;BMC Nephrology;2022-11-18

4. Soluble urokinase plasminogen activator receptor (suPAR) and glomerular disease in children: a narrative review;Egyptian Pediatric Association Gazette;2022-09-05

5. Biomarkers in Primary Focal Segmental Glomerulosclerosis in Optimal Diagnostic-Therapeutic Strategy;Journal of Clinical Medicine;2022-06-08